Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study

V.V. Foo, I.X. Pang, F.E.P. Shu, A.Y.Y. Fong, L.S. Chen, K.H. Ho,H.S. Ling, C.D. Bhavnani, L.K. Thien,B.K. Chung, Y.Y. Oon, K.T. Koh, C.T. Tan, Y.L. Cham,A. Said, T.K. Ong

International Journal of Cardiology（2022）

引用 0|浏览0

暂无评分

摘要

Hypertension is a well-recognised and modifiable risk factor that is associated with target organ damage. RDN has been shown to reduce blood pressure (BP) in patients with resistant hypertension that is attributed to an overactive renal sympathetic nervous system.

查看译文

关键词

renal denervation,resistant hypertension,rdn

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study

Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study